Cellular Research
BPC-157 + TB-500
The BPC-157 + TB-500 blend contains 10 mg of each peptide in one lyophilised research vial; the published lot report shows 99.94% HPLC purity.
99.94% HPLC purity · Lot report published
MASS
BUY ONE, GET ONE FREE · APPLIED IN YOUR CART
$54.99
Availability: In stock (can be backordered)
CHEMICAL BLOCK
The data your lab notebook needs.
Identity data for this material. Published lot reports, where one exists, are in the lab report library.
| FORM | Lyophilized Powder |
|---|---|
| CAS NUMBER | BPC-157: 137525-51-0 · TB-500: 77591-33-4 |
| MOLECULAR FORMULA | BPC-157: C62H98N16O22 · TB-500: C212H350N56O78S |
| MOLECULAR WEIGHT | BPC-157: 1419.5 g/mol · TB-500: 4963.4 g/mol |
| PURITY | Per lot (see published lab report) |
| STORAGE | Lyophilized (powder): −20°C, away from light, unopened |
COMMON QUESTIONS
Everything researchers ask before ordering.
Compound information
BPC-157 + TB-500 research data.
Two-peptide blend: BPC-157 and TB-500, 10 mg each
This product is a lyophilized blend of two peptides in one vial: BPC-157 and TB-500, 10 mg each. BPC-157 is a synthetic 15-residue linear peptide (GEPPPGKPADDAGLV, about 1419.5 g/mol). The TB-500 component is listed on the product page as thymosin beta-4, a 43-residue acetylated peptide of about 4963 g/mol. In the analytical literature, TB-500 refers to Ac-LKKTETQ, the acetylated 17-23 fragment of thymosin beta-4.
No published paper characterizes this two-peptide mixture as a defined material. The literature covers each component on its own: peptide chemistry, actin-binding biochemistry and analytical method papers. Analytical laboratories have published liquid chromatography-mass spectrometry methods that detect both peptides. The references below are limited to biochemistry and analytical papers.
| Type | Two-component peptide blend |
|---|---|
| Also listed as | BPC-157/TB-500 blend, BPC TB500 |
| Total mass | 20 mg (10 mg + 10 mg) |
| Components | 2 |
| Component | Identity |
|---|---|
| BPC-157 | 10 · GEPPPGKPADDAGLV · C62H98N16O22 · 1419.5 g/mol · CAS 137525-51-0 |
| TB-500 (listed as thymosin beta-4) | 10 · Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES · C212H350N56O78S · 4963.4 g/mol · CAS 77591-33-4 |
Lab reports
Lot reports for this product.
Each report names the lab, the lot, the test date and every assay run. Verify it on the lab's own portal.
| Lab | ILS Laboratories, San Diego, CA |
|---|---|
| Report type | Partner-facility report on the same batch Vortex stocks |
| Tested | 08/14/2026 |
| Net content | 21.12 mg (BPC-157 10.56 mg · TB-500 10.56 mg) |
| COA number | COA-2026-VHI0SA |
| Access code | HLMX7ZT9 |
Assays: Purity (HPLC), Identity (HPLC), Net content, Heavy metals (ICP-MS), Sterility (PCR), Endotoxin (USP <85>), Fentanyl screen
All published reports: lab report library →
Sources & references
Published literature.
Peer-reviewed papers on BPC-157 + TB-500, linked to PubMed.
- Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H
Cox HD, Miller GD, Eichner D. Drug Test Anal (2017). PubMed 28035768 → - Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable
Safer D, Elzinga M, Nachmias VT. J Biol Chem (1991). PubMed 1999398 →
For in-vitro laboratory research use only by qualified researchers. Not for human or veterinary consumption. Not a drug, dietary supplement or cosmetic. These statements have not been evaluated by the FDA, and this product is not intended to diagnose, treat, cure or prevent any disease. This site does not provide medical advice. Literature listed above describes published research and is not a claim about this product. By purchasing, the buyer confirms the material is for laboratory research conducted by qualified personnel.
Research library
Further reading.
Identity, analysis and storage references from the Vortex research library.
